Quantitative measurement of XLR11 and UR-144 in oral fluid by LC-MS-MS

Journal of Analytical Toxicology

Volumn 38, Issue 6, 2014, Pages 315-321

  Amaratunga, Piyadarsha ^a   Thomas, Christopher ^a   Lemberg, Bridget Lorenz ^a   Lemberg, Dave ^a  

^a Forensic Fluids Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; UNCLASSIFIED DRUG; UR144; XLR 11; (1-PENTYL-1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE; INDOLE DERIVATIVE; XLR-11;

ANALYTIC METHOD; ARTICLE; FOOD AND DRUG ADMINISTRATION; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRACTICE GUIDELINE; PYROLYSIS; SMOKING; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BODY FLUID; CHEMISTRY; DEVICES; HEAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; MOUTH; PROCEDURES; REPRODUCIBILITY; SALIVA; SUBSTANCE ABUSE;

BODY FLUIDS; CANNABINOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HOT TEMPERATURE; HUMANS; INDOLES; LIMIT OF DETECTION; MOUTH; REPRODUCIBILITY OF RESULTS; SALIVA; SOLID PHASE EXTRACTION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84904361565     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bku040     Document Type: Article

References (21)

1. Jerry, J., Collins, G., Streem, D. (2012) Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon. Cleveland Clinic Journal of Medicine, 79, 258-264.
2. Fantegrossi, W.E., Moran, J.H., Radominska-Pandya, A., Prather, P.L. (2013) Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to D(9)-THC: mechanism underlying greater toxicity? Life Science, 97, 45-54.
3. SAMHSA The Dawn Report. http://www.samhsa.gov. (Accessed December 28, 2013).
4. Choo, R.E., Huestis, M.A. (2004) Oral fluid as a diagnostic tool. Clinical Chemistry and Laboratory Medicine, 42, 1273-1287.
5. Fisher, D.S., Van Schalkwyk, G.I., Seedat, S., Curran, S.R., Flanagan, R.J. (2013) Plasma, oral fluid, and whole-blood distribution of antipsychotics and metabolites in clinical samples. Therapeutic Drug Monitoring, 35, 345-351.
6. Drummer, O. (2006) Drug testing in oral fluid. Clinical Biochemical Review, 27, 147-159.
7. Bosker, W.M., Huestis, M.A. (2009) Oral fluid testing for drugs of abuse. Clinical Chemistry, 55, 1910-1931.
8. Coulter, C., Garnier, M., Moore, C. (2011) Synthetic cannabinoids in oral fluid. Analytical Toxicology, 35, 424-430.
9. Kneisel, S., Speck, M., Moosmann, B., Corneillie, T.M., Butlin, N.G., Auwärter, V. (2013) LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows. Analytical and Bioanalytical Chemistry, 405, 4691-4706.
10. Øiestad, E.L., Johansen, U., Christophersen, A.S., Karinen, R. (2013) Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS. Bioanalysis, 5, 2257-2268.
11. Kavanagh, P., Grigoryev, A., Savchuk, S., Mikhura, I., Formanovsky, A. (2013) UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products. Drug Testing and Analysis, 5, 683-692.
12. Seely, K.A., Lapoint, J., Moran, J.H., Fattore, L. (2012) Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 39, 234-243.
13. Grigoryev, A. (2011) Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. Journal of Chromatography B, 879, 1126-1136.
14. Grigoryev, A., Kavanagh, P., Melnik, A., Savchuk, S., Simonov, A. (2013) Gas and liquid chromatography-mass spectrometry detection of the urinary metabolites of UR-144 and its major pyrolysis product. Journal of Analytical Toxicology, 37, 265-276.
15. Amaratunga, P., Lorenz Lemberg, B., Lemberg, D. (2013) Quantitative measurement of synthetic cathinones in oral fluid. Journal of Analytical Toxicology, 37, 622-628.
16. Matuszewski, B.K., Constanzer, M.L., Chavez-Eng, C.M. (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry, 75, 3019-3030.
17. Peters, F.T., Maurer, H.H. (2002) Bioanalytical method validation and its implications for forensic and clinical toxicology-A review. Accreditation and Quality Assurance, 7, 441-449.
18. Rodrigues, W.C., Catbagan, P., Rana, S., Wang, G., Moore, C. (2013) Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS. Journal of Analytical Toxicology, 37, 526-533.
19. Strano-Rossi, S., Anzillotti, L., Castrignanò, E., Romolo, F.S., Chiarotti, M. (2012) Ultra-high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, 'spice' and stimulants in oral fluid. Journal of Chromatography A, 1258, 37-42.
20. Wohlfarth, A., Pang, S., Zhu, M., Gandhi, A.S., Scheidweiler, K.B., Liu, H.F. (2013) First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry. Clinical Chemistry, 59, 1638-1648.
21. Kneisel, S., Speck, M., Moosmann, B., Auwärter, V. (2013) Stability of 11 prevalent synthetic cannabinoids in authentic neat oral fluid samples: glass versus polypropylene containers at different temperatures. Drug Testing and Analysis, 5, 602-606.